We are an NCI-designated research center that moves laboratory discoveries into viable patient treatment options. Our research saves lives. We have been involved in the development of multiple cancer therapies now used worldwide. Our research scientists work with our clinical care physicians to develop cutting-edge therapies for our patients and their families. We train the next generation of cancer researchers through post-doctoral, graduate and college programs and high school mentorships.
Have you signed up for our Spring Luncheon? It will be held at the Omni Hotel on Monday, May 7th with keynote speakers, Dr. William Henrich, President of UT Health San Antonio and his son, John Henrich, J.D.
For more information and to purchase your tickets (must be purchased by April 27) visit sacancercouncil.org/spring-luncheon
This conference is a comprehensive summary of the most up-to-date research and clinical data presented at the 2018 American Society of Clinical Oncology’s (ASCO®) Annual Meeting. Topics to be presented include Palliative and Supportive Care, Neuro Oncology, Breast Cancer-Metastatic, Hematologic Malignancies, Lung Cancer/Thoracic, Gastrointestinal Cancers, New Therapeutics, Gynecology Oncology, GU Oncology, and Breast Oncology-Adjuvant.
Description: Reiki is an ancient form of Chinese energy work that promotes relaxation and healing. Reiki treatments are provided to patients and caregivers in the chemotherapy treatment rooms. If you are not a patient scheduled to be in the treatment room, call 210-450-5570 to arrange a reiki treatment in another location.
Location: Mays Cancer Center 7979 Wurzbach Road San Antonio, Texas 78229...
Congratulations to Amelie G. Ramirez, Dr. P.H., and the Institute for Health Promotion Research (IHPR) at UT Health Science San Antonio for receiving the Icons in Healthcare Award from CentroMed, a San Antonio health and human service agency.
CentroMed established the award in 2007 to recognize individuals and entities that have made significant contributions to heal care in the community. view more
Novel technology developed at UT Health San Antonio gives rise to mouse pancreatic tumors that have the same traits as human pancreatic cancer. A U.S. patent is pending on the invention.
The groundbreaking technology, reported in February in the journal Carcinogenesis (Oxford University Press), could revolutionize studies of pancreatic cancer initiation and progression, and spur new drug development. view more
An international team led by Patricia Dahia, M.D., Ph.D., of UT Health San Antonio, discovered a genetic mutation that explains why adults with severe congenital heart defects — who live with low oxygen in their blood — are at dramatically high risk for adrenal gland cancer.
The finding was made public March 29 in the New England Journal of Medicine. view more
"We are delighted to honor the Mays Cancer Center for its 40 years of life-changing work and support its aspirations for the future."Lowry Mays, San Antonio community leader and donor to the Mays Cancer Center